Bedell Frazier Investment Counselling LLC Has $7.95 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Bedell Frazier Investment Counselling LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,720 shares of the healthcare conglomerate's stock after selling 573 shares during the quarter. UnitedHealth Group accounts for about 2.0% of Bedell Frazier Investment Counselling LLC's investment portfolio, making the stock its 16th biggest position. Bedell Frazier Investment Counselling LLC's holdings in UnitedHealth Group were worth $7,952,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the 4th quarter worth about $30,000. Promus Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $32,000. Pillar Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $40,000. Finally, DecisionPoint Financial LLC raised its position in UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock worth $52,000 after purchasing an additional 62 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Up 0.1 %

Shares of NYSE UNH traded up $0.49 during mid-day trading on Wednesday, hitting $523.61. The company had a trading volume of 2,360,406 shares, compared to its average volume of 4,265,406. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a 50-day simple moving average of $509.06 and a two-hundred day simple moving average of $542.96. The company has a market capitalization of $478.95 billion, a PE ratio of 33.78, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter last year, the company posted $5.83 earnings per share. UnitedHealth Group's quarterly revenue was up 6.8% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is 54.19%.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the company's stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 0.33% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on UNH shares. Wells Fargo & Company dropped their target price on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Hsbc Global Res raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective on the stock in a report on Friday, January 10th. Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a research report on Tuesday, December 3rd. Finally, Barclays decreased their target price on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group has an average rating of "Buy" and a consensus target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.